SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.65+2.7%Jan 30 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (8708)2/15/1999 7:30:00 PM
From: Robert S.  Read Replies (3) of 17367
 
RobertK, the articles I presented were to show that there are cost effective alternatives to expensive medical treatments. How therapeutic they are, relative to BPI, remains to be seen. I agree that oral pharmaceuticals to treat sepsis are improbable in the near future; researchers are having a difficult enough time finding efficacious intravenous treatments. Be that as it may, I don't believe one can ignore financial considerations for therapeutic treatments as you have also acknowledged:

Message 6290499
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext